lower usd
de-risk delay
follow two consecut sale ep guid down manag consid
ep fulli de-risk yoy yoy sale revis account
deal competit activ premium pet food well tough
comparison said see issu fairli isol natur premium
dog food busi name nutrish natur balanc point organ sale
declin two three remain segment flat result third
believ path growth could well extend
start found interest ceo mark smucker commentari recent challeng
execut orient need adapt quickli chang competit
action rather strateg natur fact appear incom new leadership
head sale head retail pet segment like end catalyz dramat
chang three key strateg growth imper compani dont
necessarili disagre broader growth strategi per se wonder
return equiti ttm
sale ep guid ultim enough address root issu
particularli pet along input new leader could still necessit
anoth invest year look yoy ep growth
regard quarter recogn organ sale declin yoy
line consensu howev would note ship ahead
consumpt coffe segment also look organ sale declin
acceler yoy declin expect premium pet brand nutrish
vs expect msd-hsd yoy growth previous multipl competit
entrant vie attent premium pet space fdm channel
overal take step back growth brand notabl uncrust jif powerup dunkin
caf bustelo continu grow healthi clip remain portfolio
continu pace flattish yoy sort result need deliv sjm top-lin
organ algorithm yoy believ work stabil trend
token believ still fair degre heavi lift ahead
quarterli annual ep usd
idc link barclay live interact chart
consensu number bloomberg receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
equal weight believ
cost save could deliv ep growth
believ larg reflect present
valuat also remain cautiou level
invest need spur top-lin growth well
perform pet portfolio
upsid case base
ev/ebitda multipl upsid
innov launch balanc price net
commod dynam rapid return market
invest synergi over-deliveri
downsid case base
multipl downsid ebitda estim
assum weaken consum demand
greater expect input cost inflat
greater level invest need stabil trend
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
stock
continu think profit inflect need could still bit overli
optimist could well render anoth reinvest year lower
ep estim low end sjm updat guidanc rang
predic organ sale slightli yoy full year
outlook ep growth outlook yoy yoy previous
lower price target repres ev/ebitda multipl
updat ebitda estim discount group
think appropri stage given limit visibl earn move
forward weaker top line trend previou pt repres ev/ebitda
multipl prior ebitda estim
andrew lazar herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
